Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced its financial results and business highlights for the first quarter of 2014.
“As we begin 2014, we are encouraged by the continued advances in utilization, market penetration and account growth for Lymphoseek®.
Help employers find you! Check out all the jobs and post your resume.
